Do you want to read an article? Please log in or register.
Exacerbations and Changes in Physical Activity and Sedentary Behaviour in Patients with Bronchiectasis after 1 Year
Bronchi
RECOMMENDED
Related content
COMMENTED
COPDCough
The association between daily exacerbation symptoms and physical activity in patients with chronic obstructive pulmonary disease
Int J Chron Obstruct Pulmon Dis.
Crook S, Büsching G, Keusch S, Wieser S, Turk A, Frey M, Puhan MA, Frei A
doi: 10.2147/COPD.S156986.
RECOMMENDED
Bronchi
Association between physical activity and risk of hospitalisation in bronchiectasis
★ 2
Recommended by
Dr Martin Frey, Faculty Member
Eur Respir J.
Alcaraz-Serrano V, Gimeno-Santos E, Scioscia G, Gabarrús A, Navarro A, Herrero-Cortina B, Amaro R, Fernández-Barat L, Torres A
doi: 10.1183/13993003.02138-2019.
COMMENTED
COPD
Physical activity declines in COPD while exercise capacity remains stable: A longitudinal study over 5 years
Respir Med.
Sievi NA, Brack T, Brutsche MH, Frey M, Irani S, Leuppi JD, Thurnheer R, Kohler M, Clarenbach CF
doi: 10.1016/j.rmed.2018.06.013.
Determinants of annual change in physical activity in COPD
Respirology.
Clarenbach CF, Sievi NA, Haile SR, Brack T, Brutsche MH, Frey M, Irani S, Leuppi JD, Thurnheer R, Kohler M
doi: 10.1111/resp.13035.
COPD
No impact of exacerbation frequency and severity on the physical activity decline in COPD: a long-term observation
Int J Chron Obstruct Pulmon Dis.
Sievi NA, Kohler M, Thurnheer R, Leuppi JD, Irani S, Frey M, Brutsche M, Brack T, Clarenbach CF
doi: 10.2147/COPD.
COPD
Accelerometer- versus questionnaire-based assessment of physical activity and their changes over time in patients with COPD
Int J Chron Obstruct Pulmon Dis.
Sievi NA, Brack T, Brutsche MH, Frey M, Irani S, Leuppi JD, Thurnheer R, Kohler M, Clarenbach CF
doi: 10.2147/COPD.S130195.
COPD
Physical activity patterns and clusters in 1001 patients with COPD
Chron Respir Dis.
Mesquita R, Spina G, Pitta F, Donaire-Gonzalez D, Deering BM, Patel MS, Mitchell KE, Alison J, van Gestel AJ, Zogg S, Gagnon P, Abascal-Bolado B, Vagaggini B, Garcia-Aymerich J, Jenkins SC, Romme EA, Kon SS, Albert PS, Waschki B, Shrikrishna D, Singh SJ, Hopkinson NS, Miedinger D, Benzo RP, Maltais F, Paggiaro P, McKeough ZJ, Polkey MI, Hill K, Man WD, Clarenbach CF, Hernandes NA, Savi D, Wootton S, Furlanetto KC, Cindy Ng LW, Vaes AW, Jenkins C, Eastwood PR, Jarreta D, Kirsten A, Brooks D, Hillman DR, Sant'Anna T, Meijer K, Dürr S, Rutten EP, Kohler M, Probst VS, Tal-Singer R, Gil EG, den Brinker AC, Leuppi JD, Calverley PM, Smeenk FW, Costello RW, Gramm M, Goldstein R, Groenen MT, Magnussen H, Wouters EF, ZuWallack RL, Amft O, Watz H, Spruit MA
doi: 10.1177/
RECOMMENDED
Bronchi
Efficacy of oral amoxicillin-clavulanate or azithromycin for non-severe respiratory exacerbations in children with bronchiectasis (BEST-1): a multicentre, three-arm, double-blind, randomised placebo-controlled trial
Lancet Respir Med.
Goyal V, Grimwood K, Ware RS, Byrnes CA, Morris PS, Masters IB, McCallum GB, Binks MJ, Smith-Vaughan H, O'Grady KF, Champion A, Buntain HM, Schultz A, Chatfield M, Torzillo PJ, Chang AB
doi: 10.1016/S2213-2600(19)30254-1.
RECOMMENDED
Bronchi
Validation of the Bronchiectasis Impact Measure (BIM) - a novel patient reported outcome measure
★ 2
Recommended by
Dr Martin Frey, Faculty Member
★ 2
Recommended by
Dr Marcus Hesse, Faculty Member
Eur Respir J
Crichton ML, Dudgeon EK, Shoemark A, Chalmers JD
doi: 10.1183/13993003.03156-2020